Noticias Celltex
U.S. Congressman John Culberson visits Celltex lab
Celltex proudly welcomed U.S. Congressman John Culberson, representative of the 7th District of Texas, to its offices in Houston, Texas. Celltex executive team members met with Culberson and presented him with Celltex updates and news, including partnerships for clinical research trials with Texas A&M Institute for Regenerative Medicine and Comisión Federal Para La Protección Contra Riesgos Sanitarios Comisión de Autorización Sanitaria (COFEPRIS), Mexico’s equivalent governmental regulatory body to the United States Food and Drug Administration (FDA).
Rep. Culberson also received a tour of Celltex’s state-of-the-art laboratory to observe how adult stem cells are processed in the lab, which is compliant with current Good Manufacturing Practice (cGMP) standards as recommended by the FDA for the manufacturing of biological products. He learned more about Celltex’s safety protocols and the safety testing that takes place each day to ensure the integrity of a client’s stem cells.
Celltex looks forward to working with Rep. Culberson on bringing stem cell therapy to the United States, in hopes that one day, millions of Americans in need will be able to access the regenerative power of their own adult stem cells for therapeutic purposes.
From left to right: David Eller, Celltex CEO, Chairman and Co-Founder; Congressman John Culberson; Dr. Jane Young, Celltex Chief Scientific Officer; Aditi Kaushik, Celltex Manufacturing Manager; Erik Eller, Celltex Vice President, Operations
Noticias más recientes
Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón
Celltex Therapeutics Corporation se mencionó en la publicación Stem Cell Journals como uno de los cinco ensayos de terapia con células madre más grandes que utilizan MSC para combatir el COVID en un artículo titulado “Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón umbilical”.
Leer másCompañía de Houston obtiene luz verde para estudiar sus propias células madre para prevenir COVID-19
Noticias prometedoras de Houston de una empresa que obtuvo la autorización de la FDA para intentar usar las propias células madre de una persona para prevenir el COVID-19. Celltex Therapeutics Corporation también espera que las células madre ayuden a tratar algunos de los casos más graves.
Leer más